The study, published in the American Journal of Cardiology, shines new light on a significant health issue. 

These latest findings are based on data from the VERDICT trial.

The funds will go toward establishing the Carol S. O’Neill Structural Heart Disease Research Fund.

The International League Against Epilepsy and American Epilepsy Society formed a task force to investigate this new warning, sharing its findings in Epilepsia Open. 

Researchers evaluated the imaging results and dietary habits of more than 2,500 adults, sharing their analysis in the British Journal of Nutrition.

Both procedures were a part of a clinical trial—and both occurred at the same facility.

Throughout its nearly 30-year history, atherectomy has remained something of an under-achiever.

Rather than a binary choice—atherectomy or lithotripsy—the market for treating severely calcified lesions seems likely to evolve into a mixture of both technologies. 

Cutting down on administrative costs in the U.S. healthcare industry has become a major focus over the last several years, with billions of dollars in savings to be had from automation and centralizing claims records.